ClinicalTrials.gg
RecruitingNCT07301736TRECONYUpdated Jun 25, 2026

Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma

A Phase 2 interventional study of CHF5993 pMDI with HFA-152a and CHF5993 pMDI with HFA-134a in Asthma, sponsored by Chiesi Farmaceutici S.p.A.. Recruiting at 167 sites in 14 countries. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by Chiesi Farmaceutici S.p.A. · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Started Dec 2025; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
780
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 81 studies in Asthma by Chiesi Farmaceutici S.p.A. — 11 open to participants now, 11 under way, 2 of them phase 3. Asthma · Chiesi Farmaceutici S.p.A..

Planned enrollment
9th of 66
780 · median 97
Started
2025
with 4 others
Phase 2
25 of 81
1 open now
Primary completion
2027-06
later than 5 of 10 live
Registered
76th of 81
by date

Among the 81 studies in Asthma by Chiesi Farmaceutici S.p.A., this one is the 9th largest by planned enrollment of the 66 interventional ones that give a count, is one of 5 that started in 2025, is one of 25 in phase 2, reaches primary completion later than 5 of the 10 other live ones, and was the 76th registered.

Asthma

4,848 studies on the registry are indexed under Asthma; 603 are open to participants now.

Browse Asthma studies →

Open to participants now

11 of the 81 studies in Asthma by Chiesi Farmaceutici S.p.A. are open now, in 12 countries. Recruiting first, the newest first:

5 more — sign in →

By country, each count listing its studies:

All 11 open studies →

Who these studies take

Of the 417 Asthma studies recruiting now, 140 (34%) set no upper age limit and 205 (49%) stop at 75 or younger; 147 take children under 18; 105 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Asthma by Chiesi Farmaceutici S.p.A., or all of them as a file.
02

Study summary

This study will compare an asthma inhaler that uses a new climate friendly alternative propellant to an asthma inhaler with an existing propellant. We want to make sure both versions of the inhaler work the same way for people with mild to moderate asthma.

Read the detailed description

This global study aims to compare whether the investigational inhaler with the new HFA-152a propellant is as safe, effective and well tolerated in patients with asthma as the inhalers that use the existing HFA-134a propellant. HFA-152a is a propellant gas that is designed to have a lower global warming potential and to be more climate friendly. The study will be conducted in Europe, Latin America, Ukraine, South Africa and United Kingdom. It is planned to randomize 468 patients.

03

Conditions studied

  • Asthma

Browse trials for

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male and female adults (18 ≤ age ≤ 75 years) with a diagnosis of Asthma for at least 6 months prior to screening and with diagnosis before the age of 50 years;
  • Non-smokers, ex-smokers;
  • : within the range of 18.0 to 35.0 kg/m2 inclusive;
  • Stable asthma therapy: a stable maintenance treatment for at least 4 weeks prior to screening with:

    1. low or medium doses of ICS (Inhaled ) alone; or
    2. low or medium doses of ICS + LABA (Long-acting β2-agonist) (fixed or free combination).
  • Controlled or partly controlled based on an Asthma Control Questionnaire - 7 Items (ACQ-7) score \<1.5 at screening and at randomisation.
  • Pre-BD (Bronchodilator) >40% and \<90% of the predicted normal value, after appropriate wash out from BDs, at the Screening Visit (V1).
  • A demonstrated increase in either FEV1 or forced vital capacity of >12% and >200 mL from baseline within 30 minutes (min) after inhalation of 400 µg salbutamol (i.e. albuterol) pMDI at the Screening Visit (V1).

Exclusion criteria

Exclusion Criteria:

  • History of near fatal asthma or hospitalisation for asthma in intensive care unit, inpatient setting or emergency room access for asthma in the previous 6 months prior to screening, which in the judgement of the Investigator may place the subjects at undue risk;
  • Recent asthma exacerbation requiring systemic (SCSs), or emergency room admission or hospitalisation within 3 months prior to screening and/or during the run-in period ;
  • Non-persistent asthma: exercise-induced, seasonal asthma (as the only asthma-related diagnosis) not requiring daily asthma control medicine;
  • Asthma subjects currently treated with any of the following :

    1. High dose ICS;
    2. Long-acting muscarinic antagonist (LAMA);
    3. Systemic, depot or slow-release corticosteroids within 12 weeks prior to screening;
    4. Any other asthma treatments (e.g. cromolyn sodium, nedocromil sodium, leukotriene modifiers) within 4 weeks prior to screening;
    5. Any biologic therapy (e.g. omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab, tezepelumab) within 6 months prior to screening;
  • Respiratory disorders other than asthma
  • Lung resection;
  • Lower respiratory tract infection;
  • Lung cancer and history of lung cancer;
  • Subjects with active cancer or a history of cancer (other than lungs) ;
  • Patients who have cardiovascular condition;
  • Run-in compliance: e-Diary completion \<75% and run-in treatment compliance \<75% at randomisation;
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
780 participants (estimated)

Study arms

  • Experimental
    Test Treatment: CHF5993 pMDI (Pressurised Metered Dose Inhaler) with HFA-152a

    BDP (Beclometasone Dipropionate)/FF (Formoterol Fumarate)/GB (Glycopyrronium Bromide) 100/6/12.5 µg

    Drug: CHF5993 pMDI with HFA-152a

  • Active comparator
    Reference Treatment 1: CHF5993 pMDI with HFA-134a

    BDP/FF/GB 100/6/12.5 µg

    Drug: CHF5993 pMDI with HFA-134a

  • Active comparator
    Reference Treatment 2: CHF718 pMDI with HFA-134a

    BDP 100 µg

    Drug: CHF718 pMDI with HFA-134a

Interventions

  • DrugCHF5993 pMDI with HFA-152a

    two puffs BID (twice daily)

  • DrugCHF5993 pMDI with HFA-134a

    Drug page: CHF5993

    two puffs BID

  • DrugCHF718 pMDI with HFA-134a

    two puffs BID

06

What researchers measure

Primary outcomes

  1. Change from baseline in forced expiratory volume in 1 second (FEV1) area under the curve from time zero to 4 hours (AUC0-4h) on Day 1

    Time frame: Day 1

  2. Change from baseline in pre-dose FEV1 on Day 28

    Time frame: Day 28

07

Study locations

167 of 167 sites recruiting
  • Hospital Británico de Buenos Aires_Site n. 032029
    Buenos Aires, 1275, Argentina
    Recruiting
    • Alejandro Salvado · Principal investigator
  • Centro Medico de Enfermedades Respiratorias_Site n. 032002
    Buenos Aires, 1602, Argentina
    Recruiting
    • Miguel Angel Bergna · Principal investigator
  • Centro Medico Respire_Site n. 032014
    Buenos Aires, 1646, Argentina
    Recruiting
    • Reynaldo Marciano Smith · Principal investigator
  • Asociación de Fomento y Sala de Primeros Auxilios "Alberto Mignaburu"_Site n. 032018
    Buenos Aires, 1887, Argentina
    Recruiting
    • Rocio Fernandez Bazerque · Principal investigator
  • Centro de Investigaciones Médicas Mar del Plata_Site n. 032019
    Buenos Aires, 7600, Argentina
    Recruiting
    • Manuel Naveyra · Principal investigator
  • Fundacion CIDEA_Site n. 032009
    Buenos Aires, C1121ABE, Argentina
    Recruiting
    • Jorge Maspero · Principal investigator
  • Centro Medico Arsema_Site n. 032003
    Buenos Aires, C1427BCR, Argentina
    Recruiting
    • Marcelo Casas · Principal investigator
  • Centro de Investigaciones Metabólicas (CINME)_Site n. 032025
    Ciudad Autonoma de Buenos Aire, 1056ABJ, Argentina
    Recruiting
    • Gonzalo Saenz · Principal investigator
  • Centro de Medicina Respiratoria - Concepcion del Uruguay_Site n. 032015
    Ciudad Autonoma de Buenos Aire, 1056ABJ, Argentina
    Recruiting
    • Carlos Victorio · Principal investigator
  • CARE - Centro de Alergia y Enfermedades Respiratorias_Site n. 032028
    Ciudad Autonoma de Buenos Aire, 1414, Argentina
    Recruiting
    • Andrea Di Cianni · Principal investigator
  • Consultorio Medico Dra. Rivera_Site n. 032012
    Ciudad Autonoma de Buenos Aire, 1426, Argentina
    Recruiting
    • Mariana Rivera · Principal investigator
  • Fundación Respirar Salud_Site n. 032004
    Ciudad Autonoma de Buenos Aire, 1426, Argentina
    Recruiting
    • Maria Cristina De Salvo · Principal investigator
  • Instituto de Medicina Respiratoria (IMER) - Cordoba_Site n. 032023
    Córdoba, X5003DCE, Argentina
    Recruiting
    • Alexis Cazaux · Principal investigator
  • CePIR_Site n. 032021
    La Plata, 1900, Argentina
    Recruiting
    • Gabriel Garcia · Principal investigator
  • Fundacion Scherbovsky_Site n. 032013
    Mendoza, 5500, Argentina
    Recruiting
    • Pablo Saez Scherbovsky · Principal investigator
  • Instituto Medico INSARES SA_Site n. 032005
    Mendoza, 5500, Argentina
    Recruiting
    • Pedro Elias · Principal investigator
  • Cimro Consultorios Medicos - Centro de Investigacion_Site n. 032006
    Mendoza, 5600, Argentina
    Recruiting
    • Ernesto Raso · Principal investigator
  • Centro Respiratorio Quilmes_Site n. 032007
    Quilmes, 1878, Argentina
    Recruiting
    • Marcelo Jose Fernandez · Principal investigator
  • Fundacion Innovaciencia_Site n. 032017
    Rosario, 2000, Argentina
    Recruiting
    • German Arce · Principal investigator
  • Instituto de Especialidades de la Salud Rosario_Site n. 032020
    Rosario, 2000, Argentina
    Recruiting
    • Dario Ardusso · Principal investigator
  • Instituto Medico de la Fundacion de Estudios Clínicos_Site n. 032001
    Rosario, 2000, Argentina
    Recruiting
    • Tomas Alvarez · Principal investigator
  • Fundacion Grupo Colaborativo Rosario_Site n. 032010
    Rosario, 2132, Argentina
    Recruiting
    • Fernando Massola Adrian · Principal investigator
  • Instituto De Enfermedades Respiratorias E Investigacion Medica (IERIM)_Site n. 032011
    San Juan Bautista, 1888, Argentina
    Recruiting
    • Andrea Medina · Principal investigator
  • Centro Modelo de Cardiologia SRL_Site n. 032016
    San Miguel de Tucumán, 4000, Argentina
    Recruiting
    • Roxana Maricel Willigs Rolon · Principal investigator
  • Clinica Mayo de UMCB SRL_Site n. 032026
    San Miguel de Tucumán, 4000, Argentina
    Recruiting
    • María Mercedes Espeche · Principal investigator
  • Investigaciones en Patologias Respiratorias_Site n. 032022
    San Miguel de Tucumán, T4000, Argentina
    Recruiting
    • Ana Maria Stok · Principal investigator
  • IBAMEDICA_Site n. 032008
    Santa Fe, 3000, Argentina
    Recruiting
    • Martin Edgardo Maillo · Principal investigator
  • University Clinical Centre of the Republic of Srpska - Paprikovac_Site n. 070004
    Banja Luka, 78000, Bosnia and Herzegovina
    Recruiting
    • Maja Latincic · Principal investigator
  • Sveti apostol Luka Doboj_Site n. 070005
    Doboj, 74000, Bosnia and Herzegovina
    Recruiting
    • Zeljana Panic · Principal investigator
  • Dr. Abdulah Nakas General Hospital_Site n. 070007
    Sarajevo, 71000, Bosnia and Herzegovina
    Recruiting
    • Tijana Muhic-Skalonja · Principal investigator
  • Dr. Abdulah Nakas General Hospital_Site n. 070009
    Sarajevo, 71000, Bosnia and Herzegovina
    Recruiting
    • Armin Hadzic · Principal investigator
  • Organizational unit Novi Grad_Site n. 070003
    Sarajevo, 71000, Bosnia and Herzegovina
    Recruiting
    • Alisa Krivic · Principal investigator
  • University Clinical Hospital Mostar_Site n. 07001
    Siroki Brijeg, 88226, Bosnia and Herzegovina
    Recruiting
    • Kristina Galic · Principal investigator
  • Opca Bolnica Tesanj_Site n. 070006
    Tešanj, 74260, Bosnia and Herzegovina
    Recruiting
    • Besim Prnjavorac · Principal investigator
  • Dr. Mustafa Sehovic Public Medical Center_Site n. 070008
    Tuzla, 75000, Bosnia and Herzegovina
    Recruiting
    • Edin Jusufovic · Principal investigator
  • University Clinical Centre Tuzla_Site n. 070002
    Tuzla, 75000, Bosnia and Herzegovina
    Recruiting
    • Dzenan Halilovic · Principal investigator
  • MHAT Sv. Ivan Rilski - Gorna Oryahovitsa_Site n.100017
    Gorna Oryahovitsa, 5100, Bulgaria
    Recruiting
    • Ivancho Draganchev · Principal investigator
  • Medical Center Pulmo - 2018_Site n. 100007
    Haskovo, 6300, Bulgaria
    Recruiting
    • Veselin Kalfov · Principal investigator
  • MC ZDRAVE 1 - Kozloduy_Site n. 100009
    Kozloduy, 3320, Bulgaria
    Recruiting
    • Rumen Stoyanov Tiholov · Principal investigator
  • Medical Centre Pratia Clinic EOOD - Lovech_Site n. 100012
    Lovech, 5500, Bulgaria
    Recruiting
    • Mihail Kirov · Principal investigator
  • Specialized Hospital for Active Treatment of Pulmonary Diseases - Pernik EOOD_Site n. 100020
    Pernik, 2300, Bulgaria
    Recruiting
    • Galina Petrova · Principal investigator
  • Multiprofile Hospital for Active Treatment "Heart and Brain" EAD_Site n. 100019
    Pleven, 5804, Bulgaria
    Recruiting
    • Iliya Krachunov · Principal investigator
  • Medical Centre ''Unimed'' EOOD_Site n. 100003
    Plovdiv, 4000, Bulgaria
    Recruiting
    • Maria Dimitrova · Principal investigator
  • MHAT "St. Ivan Rilski "- Razgrad_Site 100013
    Razgrad, 7200, Bulgaria
    Recruiting
    • Oleg Nemechkin · Principal investigator
  • Outpatient Practice for Specialized Medical Care in Allergology- Dr. Talyat Sali Cholak EOOD_Site 100002
    Razgrad, 7200, Bulgaria
    Recruiting
    • Talyat Cholak · Principal investigator
  • Re Spiro Medical Center_Site n. 100018
    Razgrad, 7200, Bulgaria
    Recruiting
    • Ivan Kiselov · Principal investigator
  • Medical Center Hermes Ruse_Site n. 100011
    Rousse, 7002, Bulgaria
    Recruiting
    • Nikolay Nikolaev · Principal investigator
  • SHATPPD "Dr. Dimitar Gramatikov" Ruse EOOD_Site n. 100004
    Rousse, 7002, Bulgaria
    Recruiting
    • Elena Docheva · Principal investigator
  • Multiprofile Hospital for Active Treatment "Dr. Ivan Seliminski" - Sliven AD_Site n.100014
    Sliven, 8800, Bulgaria
    Recruiting
    • Petyo Petkov · Principal investigator
  • Medical Center Hera EOOD_Site n. 100006
    Sofia, 1000, Bulgaria
    Recruiting
    • Gergana Ilieva-Georgieva · Principal investigator
  • University First Multiprofile Hospital for Active Treatment - Sofia "St. John the Baptist"_Site n. 100016
    Sofia, 1142, Bulgaria
    Recruiting
    • Dinko Valev · Principal investigator
  • Specialized Hospital for Active Treatment Pneumo- Phthisiatric Diseases - Sofia District EOOD_Site n. 100021
    Sofia, 1202, Bulgaria
    Recruiting
    • Nadya Koteva · Principal investigator
  • Multi-profile hospital for active treatment Lozenets EAD_Site n. 100008
    Sofia, 1407, Bulgaria
    Recruiting
    • Svetlomir Takov · Principal investigator
  • Preventsia 2000 - Medical Centre for Outpatient Medical Care OOD_Site n. 100005
    Stara Zagora, 6000, Bulgaria
    Recruiting
    • Vanya Dimova Ilieva-Fartunova · Principal investigator
  • University Multiprofile Hospital for Active Treatment "Prof. Dr. Stoyan Kirkovich" AD_Site n.100015
    Stara Zagora, 6000, Bulgaria
    Recruiting
    • Damyan Arabadzhiev · Principal investigator
  • Medical Centre New Rehabilitation Centre EOOD_Site n. 100010
    Stara Zagora, 6001, Bulgaria
    Recruiting
    • Gyongyver Szaloky · Principal investigator
  • Medical Centre Pratia Clinic EOOD - Varna_Site 100001
    Varna, 9020, Bulgaria
    Recruiting
    • Iskra Velichkova · Principal investigator
  • MEDITRIAL, s.r.o._Site n. 203003
    Jindřichův Hradec, 377 01, Czechia
    Recruiting
    • Petr Kopecky · Principal investigator
  • Plicni Ambulance Louny s.r.o - Louny_Site n. 203001
    Louny, 44001, Czechia
    Recruiting
    • Michala Cervena Sulcova · Principal investigator
  • Cefispiro s.r.o_Site n. 203006
    Lovosice, 41002, Czechia
    Recruiting
    • Petra Filipova · Principal investigator
  • Nemocnice Mesice - Centrum integrovane onkologicke pece, z.s., Plicni ambulance_Site n. 203004
    Měšice, 25064, Czechia
    Recruiting
    • Jaromir Musil · Principal investigator
  • MUDr. Ilona Pavlišová sro_Site n. 203007
    Miroslav, 67271, Czechia
    Recruiting
    • Ilona Pavlisova · Principal investigator
  • Plicní středisko Teplice s.r.o._Site n. 203002
    Teplice, 41501, Czechia
    Recruiting
    • Stanislav Holub · Principal investigator
  • PNEUMOLOGIE Varnsdorf_Site n. 203005
    Varnsdorf, 40747, Czechia
    Recruiting
    • Milan Sklenar · Principal investigator
  • Velocity Clinical Research Germany, Ahrensburg_Site n. 276020
    Ahrensburg, 22926, Germany
    Recruiting
    • Sameer Kulkarni · Principal investigator
  • Studienpraxis Berlin-Brandenburg_Site n. 276005
    Berlin, 10119, Germany
    Recruiting
    • Lennart Schaper · Principal investigator
  • Praxis an der Oper_Site n. 276016
    Berlin, 10625, Germany
    Recruiting
    • Thomas Lienert · Principal investigator
  • Lungenpraxis Hohenzollerndamm_Site n. 276004
    Berlin, 10717, Germany
    Recruiting
    • Anneliese Linnhoff · Principal investigator
  • Velocity Clinical Research Germany GmbH_Site 276010
    Berlin, 10787, Germany
    Recruiting
    • Isabelle Schenkenberger · Principal investigator
  • Polikum Institut GmbH_Site n. 276006
    Berlin, 12157, Germany
    Recruiting
    • Michael Sebert · Principal investigator
  • Institute for Allergy and Asthma Research Berlin, IAAB_Site n. 276008
    Berlin, 12159, Germany
    Recruiting
    • Matthias Kruell · Principal investigator
  • MECS research GmbH_Site 276011
    Berlin, 12203, Germany
    Recruiting
    • Thomas Schultz · Principal investigator
  • MECS Cottbus GmbH_Site n. 276007
    Cottbus, 03050, Germany
    Recruiting
    • Iwona Cwiek · Principal investigator
  • Klifeck GmbH_Site n. 276002
    Delitzsch, 04509, Germany
    Recruiting
    • Gerald Eckhardt · Principal investigator
  • Schwerpunktpraxis Lungen- und Bronchialheilkunde Allergologie und Schlafmedizin_Site n. 276009
    Düsseldorf, 40217, Germany
    Recruiting
    • Ulrike Neise · Principal investigator
  • Velocity Clinical Research Germany GmbH_Site n. 276019
    Hamburg, 20095, Germany
    Recruiting
    • Anastasia Kelidou · Principal investigator
  • Gemeinschaftspraxis für Pneumologie, Allergologie und Schlafmedizin_Site n. 276012
    Ibbenbueren, 49477, Germany
    Recruiting
    • Christoph Stolpe · Principal investigator
  • Pulmologische Praxis Dr. Brunner_Site n. 276013
    Leipzig, 04157, Germany
    Recruiting
    • Falk Brunner · Principal investigator
  • Velocity Clinical Research Leipzig GmbH_Site n. 276018
    Leipzig, 04177, Germany
    Recruiting
    • Thomas Muller · Principal investigator
  • Practice for pneumology and allergology_Site n. 276021
    Leipzig, 04299, Germany
    Recruiting
    • Gerhard Hoheisel · Principal investigator
  • POIS Sachsen_Site n. 276001
    Leipzig, 04347, Germany
    Recruiting
    • Juliana Brode · Principal investigator
  • Zentrum Fur Ambulante Pneumologische Forschung Mbg GbR_Site n. 276015
    Marburg, 35037, Germany
    Recruiting
    • Lukas Jerrentrup · Principal investigator
  • Ballenberger, Freytag, Wenisch - Institut fuer Klinische Forschung GmbH_Site n. 276014
    Neu-Isenburg, 63263, Germany
    Recruiting
    • Sabine Ballenberger · Principal investigator
  • Trial Pharma Kft. - TPKFT_Site n. 348011
    Békéscsaba, 5600, Hungary
    Recruiting
    • Ibolya Vendrey-Laczo · Principal investigator
  • Edelenyi Koch Robert Korhaz Es Rendelointezet_Site n. 348013
    Edelény, 3780, Hungary
    Recruiting
    • Melinda Szabo · Principal investigator
  • Szalay Janos Rendelointezet_Site n. 348006
    Hajdúnánás, 4080, Hungary
    Recruiting
    • Aniko Kurucz · Principal investigator
  • BKS Research Kft._Site n. 348001
    Hatvan, H-3000, Hungary
    Recruiting
    • Agota Bencze · Principal investigator
  • Bajcsy-Zsilinszky Korhaz es Rendelointezet_Site n. 348002
    Monor, 2200, Hungary
    Recruiting
    • Zoltan Bende Bende · Principal investigator
  • Revamed Kft._Site n. 348004
    Nyíregyháza, 4400, Hungary
    Recruiting
    • Valeria Csajbok · Principal investigator
  • Simplex Kft._Site n. 348007
    Nyíregyháza, 4481, Hungary
    Recruiting
    • Tamas Kardos · Principal investigator
  • Trial Pharma Kft. - Szeged_Site n. 348010
    Szeged, 6726, Hungary
    Recruiting
    • Gyongyver Szaloky · Principal investigator
  • Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház-Rendelőintézet_Site n. 348003
    Szolnok, 5000, Hungary
    Recruiting
    • Margit Biro · Principal investigator
  • Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz_Site n. 348005
    Szombathely, 9700, Hungary
    Recruiting
    • Zsuzsanna Cseke · Principal investigator
  • K&B Sleepmed Kft_Site n. 348008
    Szombathely, H-9700, Hungary
    Recruiting
    • Krisztina Hajdu · Principal investigator
  • VCA Polyclinic DUBULTI_Site n. 428006
    Jūrmala, 2015, Latvia
    Recruiting
    • Natalija Visocka · Principal investigator
  • Riga 1st Hospital_Site n. 428003
    Riga, 1001, Latvia
    Recruiting
    • Ilze Reinholde · Principal investigator
  • Paula Stradiņa Klīniskā Universitātes Slimnīca_Site n. 428001
    Riga, 1002, Latvia
    Recruiting
    • Aurika Babjoniseva · Principal investigator
  • Consilium Medicum_Site n. 428002
    Riga, 1010, Latvia
    Recruiting
    • Maris Bukovskis · Principal investigator
  • SIA Rigas Austrumu Kliniska Universitates Slimnica - Gailezers_Site n. 428005
    Riga, 1038, Latvia
    Recruiting
    • Inga Vikmane · Principal investigator
  • CIAID - Centro de Investigacion y Atencion Integral Durango, S.C._Site n. 484006
    Durango, 34000, Mexico
    Recruiting
    • Ricardo Alberto Ramirez Terrones · Principal investigator

Showing the first 100 of 167 sites across 14 countries. Choose a country and city above to see the rest.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Jun 2027, 17 months after the start.

Of 137 industry-sponsored phase 2 interventional studies under Asthma, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 23. This study's planned 17 months is close to that.

Counting every sponsor, half of 199 studies reached it within 20 months; a quarter within 12 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2025
First posted
Dec 24, 2025
StartActual
Dec 17, 2025
Primary completionEst.
Jun 3, 2027
CompletionEst.
Jun 3, 2027
Last update
Jun 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07301736
Responsible party
Sponsor
First posted
Dec 24, 2025
Start date
Dec 17, 2025
Primary completion
Jun 3, 2027 (estimated)
Completion
Jun 3, 2027 (estimated)
Last update
Jun 25, 2026

Study contacts

Chiesi Clinical Trial Info Chiesi Clinical Trials
Contact
clinicaltrials_info@chiesi.com
+39 0521 2791
Piotr KUNA, MD
principal investigator · Barlicki University Hospital Medical University of Lodz, Poland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion